Adaptimmune
VerifiedDevelops therapies to treat cancer.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$182m (Public information from May 2024)
Share price
$1.1 ADAP
Company register number 06456741
Milton England (HQ)